{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-065334","form_type":"8-K","ticker":"CTOR","cik":"0001851484","company_name":"CITIUS ONCOLOGY, INC.","filed_at":"2025-07-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.358538+00:00","generated_at":"2026-05-18T05:49:32.525190+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Citius Oncology closes $9.0M public offering of 6.82M shares & warrants","bullets":["Priced 6,818,182 units at $1.32 each, each consisting of 1 share + 1 warrant for 1 common share.","Gross proceeds ~$9.0M; net proceeds ~$7.44M after placement agent fees and expenses.","Warrants exercisable at $1.32/share, immediately exercisable, expire 5 years from issuance.","Proceeds to support LYMPHIR commercialization, milestone/royalty payments, and working capital.","Placement agent Maxim Group LLC; 45-day lock-up on new share issuance after closing."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-065334","json":"https://secwatch.observer/filing/0001213900-25-065334.json","markdown":"https://secwatch.observer/filing/0001213900-25-065334.md","text":"https://secwatch.observer/filing/0001213900-25-065334.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1851484/000121390025065334/0001213900-25-065334-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1851484/000121390025065334/ea0249292-8k_citius.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T05:49:32.525190+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}